Commercial strategy that gets portfolio companies sold.

We build the market position that gets a company bought. Now applied inside the hold, building toward the exit.

A GROWTH DIAGNOSTIC & MARKET INTELLIGENCE FIRM

Strategy sets the direction. Finance funds it. GTM executes it. They rarely stay in sync.

Corporate strategy, capital allocation, and go-to-market execution run on different clocks, different metrics, different incentives. The market doesn't wait for them to reconcile. That is what we diagnose.

Black outline of a circle on a white background.
Black outline of a circle on a white background.
Black outline of a circle on a white background.
Black circle on a white background.

When growth stalls, expensive guessing starts.

Your sales team blames marketing. Marketing blames product. Product blames the market. Everyone has a theory. No one has proof.


Meanwhile, you're answering to a board that wants growth and margin protection.

Download icon: Downward arrow within a rounded square.

We diagnose whether your growth strategy matches market reality.

Black circle on a white background.

We diagnose. Finance models. You decide.

We diagnose where growth capital flows and whether that deployment matches what your market rewards, today.


Your finance team translates the findings into scenarios: margin impact, cash implications, ROI models.

Black circle on a white background.

For Private Equity: In-Hold Growth Execution

Diligence validates the numbers going in. It doesn't build the commercial engine that gets the company sold on the way out. That's the work inside the hold: turning the growth thesis into the operating reality a future buyer pays for.

Financial stock chart on computer screen, blue and yellow lines.

Latest Research

4 percentage points below market. Every year.

Our analysis of 500 lower mid-market firms ($25M–$100M) over 10 years found that misaligned orientation and capital deployment is the primary driver of underperformance.

Firms with alignment grow at 7–8% against a mid-market baseline of 6%. Firms without it rarely exceed 2%, and frequently go negative.

Growth insights straight to your inbox

Once a week you'll get an article from our Substack Market Orientations. It contains our latest insights about how middle market firms can beat their competition in 2026.

Woman in white dress with arms raised, flowing fabric in a desert canyon, sunlit.

Case Study

Black arrow pointing down within a rounded square.

Private Client

A $50M company had multiple growth problems but didn't have the language or framework to identify root causes.

Observation

Four symptoms presenting as growth friction and drag:

  • Referrals slowing
  • Cross-sell stalling
  • Margin pressure
  • Missed targets

Solution

Growth Diagnostic & Strategic Advisory

Insights & Recommendation

Build market intelligence systems and realign commercial strategy — not add more resources — to accelerate growth.

Black circle with a white telephone icon.

Schedule a 30-Minute Growth Diagnostic Call

We'll explore what's driving your growth today, what might be limiting it, and whether a full diagnostic makes sense for your situation.


No pitch. No pressure. Just clarity on your next move.

Two men shaking hands in a room with brick walls, windows, and plants. One man has a beard and the other has glasses.